Marshall BioResources

Active — Near Monopoly

North Rose, New York — Global operations: US, UK, France, China, Italy, Japan

~23,000 dogsFounded 1939Beagle colony since 196220+ USDA violationsWorld's largest breeder

Overview Conditions Timeline People Evidence Legal Sources

Housing & Confinement

Marshall confines approximately 23,000 dogs in its North Rose, New York facility — the largest single concentration of purpose-bred beagles anywhere in the world. Dogs are housed in indoor sheds in standard kennel runs.

Under the Animal Welfare Act, the minimum floor space for a typical laboratory beagle (18-22 inches long) is calculated as (length + 6)² / 144 — yielding just 4.0 to 5.4 square feet per dog. For comparison, the EU mandates a minimum of 4 square meters (43 square feet) per dog under Directive 2010/63/EU — roughly 8-10× the US minimum.

4-5.4 ft²

US AWA minimum

43 ft²

EU minimum

~23,000

dogs at Marshall

~5,000

dogs at Envigo (peak)

Selective Breeding Program

Marshall has maintained its beagle colony since 1962 — over 60 years of controlled breeding. The program selects for traits that make dogs useful in research, not for the dogs' wellbeing:

Docility

Dogs that resist handling or show aggression are removed from breeding stock. Over generations, this produces animals that tolerate gavage, injection, restraint, and surgical implantation with minimal resistance — what the industry calls 'ease of handling.'

Size uniformity (8-14 kg)

Consistent body weight reduces variability in dosing studies. A drug tested at mg/kg doses produces cleaner data when all dogs weigh within a narrow range.

Low baseline variability

Organ weights, blood chemistry, and growth rates are standardized. This makes it easier to detect treatment-related effects — but it also means the 'control' animal is an artifact, not a representative dog.

Restricted immune diversity

Marshall beagles have restricted DLA class II haplotype diversity compared to pet beagles. This genetic bottleneck means vaccine and immunology study results from Marshall dogs may not predict responses in the broader canine population.

Reproductive output

Selection for reliable fertility and adequate litter sizes (average 5.4 puppies). Colony perinatal mortality rate is ~12.9%, compared to ~8% cross-breed average.

USDA Violation Record

Marshall has been cited for more than 20 AWA violations since 2007, documented by USDA APHIS and compiled by Rise for Animals. Despite this record, Marshall has never faced enforcement comparable to Envigo (which was shut down for 70+ violations and faced a $35M penalty).

Data Gap

Detailed breakdown of Marshall's specific USDA violations is limited in public sources. Rise for Animals has compiled records, but individual inspection reports with violation specifics are not as thoroughly documented in public reporting as Envigo's or Ridglan's records. This opacity is itself significant — Marshall's private status shields it from the disclosure that publicly-traded Inotiv (Envigo's parent) was subject to.

Comparison with Other Facilities

Factor	Marshall	Envigo	Ridglan
Dogs at peak	~23,000	~5,000	~3,200
AWA violations	20+	70+	311 (DATCP)
Enforcement action	None comparable	Federal shutdown, $35M fine	License surrender July 2026
Corporate structure	Private	Public (Inotiv/NASDAQ)	Private
Status	Active	Closed 2022	Closing July 2026

Key Finding

Expert veterinary testimony in the Ridglan case (Dr. Sherstin Rosenberg) described Ridglan's conditions as “significantly worse than facilities shut down by the federal government such as Envigo.” No comparable independent veterinary assessment of Marshall's conditions has been published.